ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 93 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 2.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $70,000 | +20.7% | 22,250 | 0.0% | 0.00% | – |
| Q4 2016 | $58,000 | -33.3% | 22,250 | 0.0% | 0.00% | – |
| Q3 2016 | $87,000 | +45.0% | 22,250 | 0.0% | 0.00% | – |
| Q2 2016 | $60,000 | -15.5% | 22,250 | +21.6% | 0.00% | – |
| Q1 2015 | $71,000 | -45.4% | 18,296 | -5.2% | 0.00% | -100.0% |
| Q4 2014 | $130,000 | +22.6% | 19,292 | 0.0% | 0.00% | – |
| Q3 2014 | $106,000 | -45.6% | 19,292 | +1.6% | 0.00% | -100.0% |
| Q2 2014 | $195,000 | -9.3% | 18,993 | +5.9% | 0.00% | 0.0% |
| Q1 2014 | $215,000 | +4.4% | 17,930 | -1.6% | 0.00% | 0.0% |
| Q4 2013 | $206,000 | +3.0% | 18,220 | -1.8% | 0.00% | 0.0% |
| Q3 2013 | $200,000 | +222.6% | 18,545 | +177.0% | 0.00% | – |
| Q2 2013 | $62,000 | – | 6,696 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
| Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
| Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
| Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
| HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
| Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
| Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |
| Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |